Physician
ST. Peter's Hospital of the City of Albany
ST. Peter's Hospital of the City of Albany was paid $7.54M by Medicaid between Oct 2021 and Dec 2024, across 242 billing codes. Its largest line is H0005, Alcohol and/or drug services; group counseling by a clinician — 8.5% of everything it billed.
33Billing provider infoST. PETER'S HOSPITAL OF THE CITY OF ALBANY
ALBANY, NY 12208
ALBANY, NY 12208
33aNPI1518042357assigned 10/26/2006
33bProvider typeFamily Medicine Physician
28Total paid$7.54M
24GClaims191,620
24DCodes billed242
24AFirst – last monthOct 2021 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in New York
Rank by total paid#17 of 2,605
Median peer was paid$10K
This provider vs. median747×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official KNOWLES, COURTNEY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 33 | $2K | |
| 2022 | 519 | $22K | |
| 2023 | 99,160 | $3.95M | |
| 2024incomplete | 91,908 | $3.57M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| H0005 | Alcohol and/or drug services; group counseling by a clinician | 8.5% | 4,502 | 917 | $639K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 7.4% | 4,788 | 4,247 | $558K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.4% | 5,606 | 5,205 | $405K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.1% | 4,190 | 4,042 | $385K |
| S9480 | Intensive outpatient psychiatric services, per diem | 3.4% | 1,824 | 219 | $256K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 3.2% | 1,664 | 1,581 | $238K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 3.1% | 1,685 | 392 | $230K |
| 96361 | Intravenous infusion, hydration; each additional hour | 3.0% | 1,079 | 928 | $223K |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | 2.7% | 1,287 | 950 | $200K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.6% | 1,466 | 1,371 | $193K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 2.4% | 1,246 | 1,111 | $182K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.3% | 700 | 680 | $177K |
230 more codes
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.1% | 1,910 | $155K |
| 80053 | Comprehensive metabolic panel | 2.1% | 10,088 | $155K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.9% | 3,043 | $143K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.8% | 1,660 | $133K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.7% | 483 | $126K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.6% | 3,694 | $123K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.6% | 335 | $119K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.6% | 1,487 | $118K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.5% | 809 | $112K |
| 99222 | Initial hospital care, per day, moderate complexity | 1.5% | 1,445 | $111K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1.4% | 380 | $108K |
| H0050 | Alcohol and/or drug services, brief intervention, per 15 minutes | 1.2% | 502 | $89K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.2% | 1,016 | $88K |
| 99223 | Prolong inpt eval add15 m | 1.2% | 885 | $87K |
| 36415 | Collection of venous blood by venipuncture | 1.1% | 14,152 | $86K |
| 93975 | 1.0% | 206 | $77K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 474 | $71K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 513 | $66K |
| G0378 | Hospital observation service, per hour | <1% | 1,070 | $63K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 1,302 | $63K |
| T1023 | Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter | <1% | 655 | $63K |
| G0397 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and intervention, greater than 30 minutes | <1% | 411 | $58K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 1,067 | $55K |
| 86900 | <1% | 906 | $53K | |
| 88342 | <1% | 461 | $52K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 407 | $49K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,969 | $49K |
| 90461 | <1% | 1,500 | $47K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,012 | $47K |
| 80061 | Lipid panel | <1% | 3,677 | $46K |
| 99460 | <1% | 731 | $43K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 580 | $43K |
| H0004 | Behavioral health counseling and therapy, per 15 minutes | <1% | 290 | $42K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,461 | $42K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 345 | $41K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 278 | $39K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 614 | $37K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 105 | $37K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 245 | $35K |
| H0002 | Behavioral health screening to determine eligibility for admission to treatment program | <1% | 207 | $35K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,461 | $33K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 477 | $30K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 9,544 | $29K |
| 76641 | <1% | 300 | $27K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 604 | $26K |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | <1% | 561 | $24K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 377 | $24K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 508 | $24K |
| Q9992 | Injection, buprenorphine extended-release (sublocade), greater than 100 mg | <1% | 13 | $22K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,089 | $20K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 202 | $19K |
| 86850 | <1% | 929 | $18K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,071 | $18K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 27 | $17K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 580 | $17K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 68 | $17K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 545 | $16K |
| 93017 | <1% | 109 | $15K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,033 | $14K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,946 | $13K |
| 90686 | <1% | 901 | $13K | |
| 86780 | <1% | 1,162 | $13K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,197 | $12K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 400 | $12K |
| G0475 | Hiv antigen/antibody, combination assay, screening | <1% | 495 | $12K |
| 83880 | <1% | 421 | $11K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 842 | $11K |
| 84439 | <1% | 2,038 | $11K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 78 | $10K |
| 82607 | <1% | 953 | $10K | |
| 90651 | <1% | 352 | $9K | |
| 93970 | <1% | 16 | $9K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 171 | $9K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,466 | $8K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 544 | $8K |
| 86901 | <1% | 915 | $8K | |
| 90648 | <1% | 432 | $8K | |
| 0223U | <1% | 165 | $8K | |
| 99385 | <1% | 103 | $8K | |
| 86480 | <1% | 131 | $7K | |
| 0352U | <1% | 147 | $6K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,257 | $6K |
| 82728 | <1% | 762 | $6K | |
| 99462 | <1% | 223 | $6K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 736 | $6K |
| 90715 | <1% | 236 | $6K | |
| 96127 | <1% | 2,996 | $6K | |
| 90723 | <1% | 269 | $6K | |
| 90633 | <1% | 309 | $5K | |
| 76937 | <1% | 30 | $5K | |
| 83655 | <1% | 595 | $5K | |
| 76830 | Ultrasound, transvaginal | <1% | 107 | $5K |
| 90677 | <1% | 219 | $5K | |
| 88142 | <1% | 216 | $5K | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 1,120 | $5K |
| 85027 | <1% | 1,663 | $5K | |
| 83550 | <1% | 935 | $5K | |
| 90670 | <1% | 269 | $4K | |
| 84153 | <1% | 296 | $4K | |
| 87660 | <1% | 451 | $4K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 965 | $4K |
| 82570 | <1% | 1,076 | $4K | |
| 82043 | <1% | 935 | $4K | |
| 83540 | <1% | 985 | $4K | |
| 99406 | <1% | 206 | $4K | |
| 82746 | <1% | 393 | $4K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 692 | $4K |
| 87480 | <1% | 411 | $4K | |
| 87510 | <1% | 410 | $4K | |
| 87653 | <1% | 122 | $4K | |
| 85610 | <1% | 991 | $3K | |
| 90656 | <1% | 246 | $3K | |
| 59025 | Fetal non-stress test | <1% | 133 | $3K |
| 99221 | <1% | 62 | $3K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 28 | $3K |
| 70496 | <1% | 12 | $3K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 164 | $3K |
| 90734 | <1% | 129 | $3K | |
| 95806 | <1% | 24 | $3K | |
| 84702 | <1% | 415 | $3K | |
| 81001 | <1% | 1,992 | $3K | |
| 87563 | <1% | 102 | $2K | |
| 86803 | <1% | 401 | $2K | |
| 90710 | <1% | 98 | $2K | |
| 83735 | <1% | 1,483 | $2K | |
| H0001 | Alcohol and/or drug assessment | <1% | 15 | $2K |
| 87340 | <1% | 557 | $2K | |
| 76801 | <1% | 17 | $2K | |
| 90681 | <1% | 91 | $2K | |
| 84481 | <1% | 124 | $2K | |
| H0033 | Oral medication administration, direct observation | <1% | 69 | $2K |
| 90696 | <1% | 61 | $2K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 13 | $1K |
| 86038 | <1% | 159 | $1K | |
| 71045 | Radiologic examination, chest; single view | <1% | 964 | $1K |
| 71250 | <1% | 13 | $1K | |
| 90716 | <1% | 42 | $1K | |
| 86140 | <1% | 451 | $1K | |
| 82105 | <1% | 82 | $989.43 | |
| 88304 | <1% | 61 | $977.04 | |
| 86762 | <1% | 271 | $942.10 | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 45 | $919.17 |
| 81003 | <1% | 1,055 | $891.84 | |
| 87077 | <1% | 267 | $790.91 | |
| 85652 | <1% | 549 | $790.60 | |
| 82950 | <1% | 183 | $784.79 | |
| 88307 | <1% | 12 | $744.00 | |
| 87428 | <1% | 14 | $741.57 | |
| 83970 | <1% | 25 | $734.24 | |
| 83690 | <1% | 1,108 | $733.26 | |
| 80074 | <1% | 25 | $732.59 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 14 | $713.15 |
| 87186 | <1% | 199 | $659.30 | |
| 86706 | <1% | 80 | $656.76 | |
| 84403 | <1% | 27 | $611.37 | |
| 86765 | <1% | 135 | $610.64 | |
| 84703 | <1% | 1,265 | $574.17 | |
| 86787 | <1% | 209 | $562.13 | |
| 86431 | <1% | 95 | $487.19 | |
| 84484 | <1% | 1,661 | $474.91 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 776 | $459.36 |
| 83520 | <1% | 32 | $450.84 | |
| 86618 | <1% | 37 | $429.86 | |
| 87522 | Neg quan hep c or qual rna | <1% | 12 | $404.90 |
| 84100 | <1% | 444 | $401.04 | |
| 90707 | <1% | 15 | $376.50 | |
| 90620 | <1% | 14 | $351.40 | |
| 82784 | <1% | 40 | $297.60 | |
| 85018 | <1% | 405 | $291.53 | |
| 84550 | <1% | 99 | $282.52 | |
| 91320 | <1% | 36 | $274.36 | |
| 84146 | <1% | 14 | $251.94 | |
| 82248 | <1% | 49 | $220.88 | |
| 90700 | <1% | 12 | $214.20 | |
| 85730 | <1% | 427 | $209.17 | |
| 82962 | <1% | 186 | $200.10 | |
| 86800 | <1% | 13 | $190.92 | |
| 84156 | <1% | 96 | $173.89 | |
| 90480 | <1% | 42 | $164.00 | |
| 86376 | <1% | 12 | $160.05 | |
| 87070 | <1% | 41 | $129.30 | |
| 87040 | <1% | 350 | $122.72 | |
| 83605 | <1% | 532 | $92.85 | |
| 81025 | <1% | 55 | $66.89 | |
| 85379 | <1% | 170 | $61.08 | |
| 82805 | <1% | 32 | $48.68 | |
| 83615 | <1% | 12 | $37.86 | |
| 82550 | <1% | 17 | $32.55 | |
| 85045 | <1% | 13 | $7.98 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 913 | $4.20 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 373 | $1.98 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 474 | $0.00 |
| 3079F | 0% | 405 | $0.00 | |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 0% | 56 | $0.00 |
| 3008F | 0% | 2,263 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 766 | $0.00 |
| 96376 | 0% | 481 | $0.00 | |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 276 | $0.00 |
| 3074F | 0% | 1,796 | $0.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 887 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 284 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 943 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 305 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 165 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 1,076 | $0.00 |
| J1815 | Injection, insulin, per 5 units | 0% | 122 | $0.00 |
| C1769 | Guide wire | 0% | 56 | $0.00 |
| 3044F | 0% | 186 | $0.00 | |
| 3075F | 0% | 28 | $0.00 | |
| 70498 | 0% | 12 | $0.00 | |
| J2060 | Injection, lorazepam, 2 mg | 0% | 33 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 0% | 27 | $0.00 |
| 84132 | 0% | 15 | $0.00 | |
| 3078F | 0% | 1,326 | $0.00 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 1,761 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 1,314 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 1,435 | $0.00 |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 35 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 153 | $0.00 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 0% | 138 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 63 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 446 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 1,308 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 495 | $0.00 |
| G9920 | Screening performed and negative | 0% | 91 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 0% | 94 | $0.00 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 28 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 26 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 22 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 53 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKNOWLES, COURTNEY (CREDENTIALING & ENROLLMENT MANAGER)
Parent organizationST. PETER'S HOSPITAL OF THE CITY OF ALBANY
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.